Intellia Therapeutics Inc (FRA:38I)
€ 21.9 0.64 (3.01%) Market Cap: 2.32 Bil Enterprise Value: 1.69 Bil PE Ratio: 0 PB Ratio: 2.40 GF Score: 57/100

Q4 2020 Intellia Therapeutics Inc Earnings Call Transcript

Feb 25, 2021 / 01:00PM GMT
Release Date Price: €47.73 (-8.95%)
Operator

Good morning. My name is Andrew, and I will be your conference operator today, and welcome to the Intellia Therapeutics Fourth Quarter 2020 Earnings Conference Call. (Operator Instructions) Please be advised that this call is being recorded at the company's request. (Operator Instructions)

At this time, I would like to turn it over to Josh Rappaport, Managing Director at Stern Investor Relations. Please go ahead.

Josh Rappaport

Thank you, operator. Good morning, everyone, and welcome to Intellia's fourth quarter and full year 2020 earnings call. Earlier today, Intellia issued a press release outlining the company's progress this quarter and the topics for discussion on today's call. This release can be found on the Investors and Media section of Intellia's website at intelliatx.com. This call is being broadcast live, and a replay will also be archived on the company's website.

Before we get started, I'd like to remind you that during this call, Intellia management may make certain forward-looking statements and ask that you refer to SEC filings

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot